CR Bard - Europe, Middle East and Africa (EMEA)
Key Highlights
- CR Bard - EMEA is a pioneer in the development of single-use medical products for hospital procedures, enhancing patient care and reducing costs.
- The company's innovative approach to medical technology development has positioned it as a leader in the healthcare industry.
- CR Bard - EMEA's global market reach and commitment to technological advancements make it a key player in the medical technology sector.
- The company's strategic focus on vascular, urology, oncology, and surgical specialties allows it to address a wide range of healthcare needs.
- CR Bard - EMEA's integration with BD has strengthened its market presence and ability to deliver innovative medical solutions.
About CR Bard - Europe, Middle East and Africa (EMEA)
CR Bard - Europe, Middle East and Africa (EMEA) is a leading multinational developer, manufacturer, and marketer of innovative medical technologies in vascular, urology, oncology, and surgical specialties. The company has joined BD and is committed to technological innovations that offer superior clinical benefits while reducing overall healthcare costs. Based in Winnersh, Wokingham, United Kingdom, CR Bard - EMEA markets its products and services worldwide to hospitals, healthcare professionals, and facilities.
CR Bard - EMEA has a strong focus on pioneering single-use medical products for hospital procedures. The company's commitment to innovation is evident in its pursuit of technologies that enhance patient care and reduce healthcare costs. With a public company structure, CR Bard - EMEA continues to expand its market presence and impact in the medical technology sector.
The company's strategic approach to medical technology development and its global market reach make it a key player in the healthcare industry. CR Bard - EMEA's dedication to improving patient outcomes through its innovative products and services positions it as a leader in the medical technology field.
Company Facts
| Ownership Private Company |
| Parent Company BD |
Why Contact CR Bard - Europe, Middle East and Africa (EMEA)?
B2B professionals would contact CR Bard - EMEA for its innovative medical technologies and commitment to reducing healthcare costs. The company offers opportunities for partnerships and vendor collaborations in the medical technology sector.
Who Should Contact CR Bard - Europe, Middle East and Africa (EMEA) for Business?
Sales teams selling medical technologies, healthcare professionals, and facilities should reach out to CR Bard - EMEA. Recruiters seeking roles in medical technology development and operational roles should also consider this company.
Categories
- Medical Technology
- Innovative Products
- Healthcare Solutions
- Vascular
- Urology
- Oncology
- Surgical Specialties
- Single-Use Medical Products
- Clinical Benefits
- Healthcare Costs
More Medical Technology Companies
Frequently Asked Questions
- What does CR Bard - Europe, Middle East and Africa (EMEA) do?
- CR Bard - Europe, Middle East and Africa (EMEA) is a medical devices company that develops, manufactures, and markets medical technologies in the fields of vascular, urology, oncology, and surgical specialties.
- How many employees does CR Bard - Europe, Middle East and Africa (EMEA) have?
- CR Bard - Europe, Middle East and Africa (EMEA) has approximately 135 employees.
- Where is CR Bard - Europe, Middle East and Africa (EMEA) headquartered?
- The company is located in the United Kingdom.
- What industry is CR Bard - Europe, Middle East and Africa (EMEA) in?
- CR Bard - Europe, Middle East and Africa (EMEA) operates in Medical Technology, Healthcare Solutions, Innovative Medical Products.
- Is CR Bard - Europe, Middle East and Africa (EMEA) still active?
- Yes, CR Bard - Europe, Middle East and Africa (EMEA) was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to CR Bard - Europe, Middle East and Africa (EMEA)?
- Research CR Bard - Europe, Middle East and Africa (EMEA)'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to CR Bard - Europe, Middle East and Africa (EMEA)?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with CR Bard - Europe, Middle East and Africa (EMEA)